HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Armin Bollow Selected Research

Armin Bollow Research Topics

Disease

26Ventricular Tachycardia
01/2022 - 01/2018
9Death (Near-Death Experience)
10/2023 - 10/2018
6Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 01/2019
4Heart Failure
10/2019 - 01/2019
3Cardiogenic Shock
10/2023 - 05/2019
3Chronic Renal Insufficiency
10/2023 - 06/2019
3Atrial Fibrillation
06/2021 - 01/2019
2ST Elevation Myocardial Infarction
10/2023 - 01/2022
2Non-ST Elevated Myocardial Infarction
10/2023 - 01/2022
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2019
2Cardiomyopathies (Cardiomyopathy)
03/2020 - 08/2019
1Myocardial Infarction
10/2023
1Left Ventricular Dysfunction
10/2023
1Heart Diseases (Heart Disease)
01/2022
1Systolic Heart Failure
01/2021
1Hypokalemia
03/2020
1Hyperkalemia
03/2020
1Shock
11/2019
1Heart Arrest (Cardiac Arrest)
06/2019
1Cardiac Sudden Death (Sudden Cardiac Arrest)
06/2019
1Chronic Obstructive Pulmonary Disease (COPD)
12/2018

Drug/Important Bio-Agent (IBA)

6omega-Chloroacetophenone (Mace)IBA
01/2023 - 01/2019
2Amiodarone (Amiodarona)FDA LinkGeneric
03/2021 - 02/2019
2PotassiumIBA
10/2020 - 03/2020
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2019 - 01/2018
2Angiotensin Receptor AntagonistsIBA
01/2019 - 01/2018
1Eplerenone (Inspra)FDA LinkGeneric
01/2021
1Spironolactone (Aldactone)FDA LinkGeneric
01/2021
1Mineralocorticoid Receptor AntagonistsIBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2019
1AF 14IBA
01/2019

Therapy/Procedure

22Therapeutics
01/2022 - 12/2018
14Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
10/2023 - 01/2019
12Patient Readmission
01/2023 - 10/2018
4Cardiopulmonary Resuscitation (CPR)
10/2023 - 05/2019
2Percutaneous Coronary Intervention
01/2022 - 10/2018
1Secondary Prevention
08/2019
1Renal Replacement Therapy (Therapies, Renal Replacement)
06/2019